Bernard J. Cassidy is CLO & Secretary at Juno Therapeutics, Inc. (JUNO). They have made 8 open-market trades across 2 companies since 2009, most recently 2025-03-10.
CIK 0001594864
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JUNO | SELL | 2017-09-14 | 2017-09-14 | $44.92 | $2.5M | -4.9% | -3.0% | +7.3% |
| JUNO | SELL | 2016-05-19 | 2016-05-20 | $38.92 | $208K | +10.7% | +6.7% | -16.3% |
| JUNO | SELL | 2016-04-19 | 2016-04-19 | $43.12 | $138K | -2.8% | -9.3% | -34.2% |
| JUNO | SELL | 2016-03-18 | 2016-03-18 | $38.18 | $244K | -2.0% | +14.4% | +10.4% |
| JUNO | SELL | 2016-02-19 | 2016-02-19 | $34.47 | $214K | +18.9% | +8.9% | +9.3% |
| JUNO | SELL | 2016-01-19 | 2016-01-20 | $33.37 | $80K | -17.1% | +8.4% | +31.4% |
| JUNO | SELL | 2016-01-19 | 2016-01-20 | $33.55 | $107K | -17.1% | +8.4% | +31.4% |
| JUNO | SELL · 10b5-1 | 2015-12-18 | 2015-12-21 | $45.39 | $145K | -18.7% | -22.8% | -9.3% |
| JUNO | SELL · 10b5-1 | 2015-11-19 | 2015-11-20 | $52.97 | $170K | -18.7% | +1.3% | -17.1% |
| JUNO | SELL · 10b5-1 | 2015-10-19 | 2015-10-19 | $49.85 | $160K | -18.7% | +1.3% | -26.3% |
| JUNO | SELL · 10b5-1 | 2015-09-18 | 2015-09-18 | $42.50 | $504K | -18.7% | +1.3% | +1.3% |
| JUNO | SELL · 10b5-1 | 2015-08-19 | 2015-08-20 | $40.14 | $476K | -18.7% | +1.3% | +1.3% |
| JUNO | SELL · 10b5-1 | 2015-07-17 | 2015-07-17 | $50.54 | $599K | -18.7% | +1.3% | +1.3% |
| JUNO | SELL · 10b5-1 | 2015-06-24 | 2015-06-25 | $51.34 | $608K | -18.7% | +1.3% | +1.3% |
| TSRA | SELL · 10b5-1 | 2013-03-06 | 2013-03-07 | $17.75 | $53K | -8.8% | -0.3% | -0.3% |
| TSRA | SELL · 10b5-1 | 2013-02-01 | 2013-02-04 | $17.49 | $31K | -8.8% | -0.3% | -0.3% |
| TSRA | SELL · 10b5-1 | 2012-12-24 | 2012-12-27 | $16.29 | $83K | -8.8% | -0.3% | -0.3% |
| TSRA | SELL · 10b5-1 | 2012-02-15 | 2012-02-17 | $19.24 | $37K | -8.8% | -0.3% | -0.3% |
| TSRA | SELL · 10b5-1 | 2012-02-01 | 2012-02-02 | $19.63 | $32K | -8.8% | -0.3% | -0.3% |
| TSRA | SELL · 10b5-1 | 2011-11-17 | 2011-11-18 | $17.24 | $86K | -8.8% | -0.3% | -0.3% |
| TSRA | SELL · 10b5-1 | 2011-08-01 | 2011-08-02 | $16.02 | $3K | -8.8% | -0.3% | -0.3% |
| TSRA | SELL · 10b5-1 | 2011-02-16 | 2011-02-18 | $17.64 | $66K | -8.8% | -0.3% | -0.3% |
| TSRA | SELL · 10b5-1 | 2011-02-01 | 2011-02-03 | $17.39 | $35K | -8.8% | -0.3% | -0.3% |
| TSRA | SELL · 10b5-1 | 2010-11-18 | 2010-11-19 | $20.63 | $103K | -8.8% | -0.3% | -0.3% |
| TSRA | SELL · 10b5-1 | 2010-08-02 | 2010-08-02 | $17.10 | $12K | -8.8% | -0.3% | -0.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.